Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMA House of Delegates

This article was originally published in The Tan Sheet

Executive Summary

Will consider a proposed resolution suggesting Medicaid coverage of OTC drugs at the group's June 13-17 meeting in Chicago. The resolution, submitted by the American Medical Association's student section, urges the association to "study possible changes in Medicaid coverage policy such that Medicaid pay for OTC drugs when, by a consensus of current medical knowledge, those drugs are deemed the drug of choice for a given diagnosis or illness." The resolution notes that some state Medicaid programs do not cover certain OTC products, putting physicians "in a situation wherein they must prescribe an alternative medication which is often less efficacious, more toxic and more expensive to Medicaid".
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel